Nordea Investment Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-460,641
| Closed | -$986K | – | 879 |
|
|
2024
Q4 | $986K | Buy |
460,641
+9,635
| +2% | +$20.6K | ﹤0.01% | 810 |
|
|
2024
Q3 | $1.3M | Sell |
451,006
-183,654
| -29% | -$531K | ﹤0.01% | 773 |
|
|
2024
Q2 | $1.48M | Sell |
634,660
-107,454
| -14% | -$250K | ﹤0.01% | 747 |
|
|
2024
Q1 | $3.38M | Buy |
742,114
+1,431
| +0.2% | +$6.52K | ﹤0.01% | 618 |
|
|
2023
Q4 | $2.38M | Sell |
740,683
-23,805
| -3% | -$76.5K | ﹤0.01% | 673 |
|
|
2023
Q3 | $2.42M | Sell |
764,488
-10,807
| -1% | -$34.2K | ﹤0.01% | 660 |
|
|
2023
Q2 | $3.73M | Buy |
775,295
+129,667
| +20% | +$624K | 0.01% | 578 |
|
|
2023
Q1 | $3.25M | Sell |
645,628
-7,187
| -1% | -$36.2K | ﹤0.01% | 606 |
|
|
2022
Q4 | $3.9M | Sell |
652,815
-11,487
| -2% | -$68.7K | 0.01% | 567 |
|
|
2022
Q3 | $6.96M | Sell |
664,302
-34,906
| -5% | -$365K | 0.01% | 438 |
|
|
2022
Q2 | $7.87M | Sell |
699,208
-60,468
| -8% | -$681K | 0.01% | 420 |
|
|
2022
Q1 | $7.28M | Buy |
759,676
+342,237
| +82% | +$3.28M | 0.01% | 503 |
|
|
2021
Q4 | $6.46M | Buy |
417,439
+112,028
| +37% | +$1.73M | 0.01% | 533 |
|
|
2021
Q3 | $7.92M | Sell |
305,411
-5,895
| -2% | -$153K | 0.01% | 468 |
|
|
2021
Q2 | $8.12M | Buy |
311,306
+142,323
| +84% | +$3.71M | 0.01% | 458 |
|
|
2021
Q1 | $5.93M | Sell |
168,983
-6,823
| -4% | -$239K | 0.01% | 549 |
|
|
2020
Q4 | $4.44M | Sell |
175,806
-3,438
| -2% | -$86.8K | 0.01% | 598 |
|
|
2020
Q3 | $6.72M | Sell |
179,244
-176,302
| -50% | -$6.61M | 0.01% | 388 |
|
|
2020
Q2 | $14.9M | Buy |
355,546
+177,777
| +100% | +$7.45M | 0.02% | 357 |
|
|
2020
Q1 | $3.46M | Buy |
177,769
+6,638
| +4% | +$129K | 0.01% | 533 |
|
|
2019
Q4 | $4.47M | Buy |
+171,131
| New | +$4.47M | 0.01% | 582 |
|